EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)VergleichsstudieMultizentrische StudieRandomisierte kontrollierte Studie

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―

Kenji Kanenawa, Ko Yamamoto, Takenori Domei, Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Yuki Obayashi, Ryusuke Nishikawa, Tomoya Kimura, Kenji Ando, Satoru Suwa, Tsuyoshi Isawa und 14 weitere

Circulation Journal · 24.07.2026 · 90 (8) · 1055-1065

DOI: 10.1253/circj.cj-25-1114 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Circulation Journal, erschienen am 24.07.2026. Verfasst von Kenji Kanenawa und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kokura Memorial Hospital. Hauptthemen laut MEDLINE: Aspirin, Clopidogrel, Diabetes Mellitus, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinClopidogrelDiabetes MellitusPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsAgedFemaleHumansMaleMiddle AgedTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Antiplatelet therapyCoronary stentDiabetesPercutaneous coronary intervention

Substanzen

AspirinClopidogrelPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, Kokura Memorial Hospital.
  • Department of Cardiovascular Medicine, Saga University.
  • Department of Cardiology, Hirakata Kohsai Hospital.
  • Department of Clinical Epidemiology, Hyogo College of Medicine.
  • Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine.
  • Department of Cardiology, Japanese Red Cross Wakayama Medical Center.

Zitieren

APA

Kanenawa, K., Yamamoto, K., Domei, T., Natsuaki, M., Watanabe, H., Morimoto, T., Obayashi, Y., Nishikawa, R., Kimura, T., Ando, K., Suwa, S., Isawa, T., Takenaka, H., Ishikawa, T., Yamada, M., Wakatsuki, T., Nozaki, Y., Kitahara, H., Kato, R., …, & STOPDAPT-3 Investigators (2026). Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―. Circulation Journal, 90(8), 1055-1065. https://doi.org/10.1253/circj.cj-25-1114

Vancouver

Kanenawa K, Yamamoto K, Domei T, Natsuaki M, Watanabe H, Morimoto T, et al. Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―. Circulation Journal. 2026;90(8):1055-1065. doi:10.1253/circj.cj-25-1114

BibTeX
@article{Kanenawa2026,
  author = {Kanenawa, Kenji and Yamamoto, Ko and Domei, Takenori and Natsuaki, Masahiro and Watanabe, Hirotoshi and Morimoto, Takeshi and Obayashi, Yuki and Nishikawa, Ryusuke and Kimura, Tomoya and Ando, Kenji and Suwa, Satoru and Isawa, Tsuyoshi and Takenaka, Hiroyuki and Ishikawa, Tetsuya and Yamada, Minoru and Wakatsuki, Tetsuzo and Nozaki, Yoichi and Kitahara, Hideki and Kato, Ryuichi and Kawai, Ryoma and Kobayashi, Yohei and Ishii, Mitsuru and Goto, Yoshitaka and Ono, Koh and Kimura, Takeshi and STOPDAPT-3 Investigators, STOPDAPT-3 Investigators},
  title = {Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes ― Prespecified Subgroup Analysis of the STOPDAPT-3 Trial ―},
  journal = {Circulation Journal},
  year = {2026},
  volume = {90},
  number = {8},
  pages = {1055--1065},
  doi = {10.1253/circj.cj-25-1114}
}
Kostenlos starten →